Bridging funding to enable faster access to medicines in Australia

As a member of the Bridging Funding Coalition, we support the release of a national consensus statement for bridging funding. This would provide earlier, faster, and fairer access to new medicines, bridging the gap between TGA registration and PBS funding, where there is a high unmet need, and patients cannot afford the additional expense and the time to wait for a medicine to be listed on the PBS.

We are calling on the Government to ensure Australian patients get faster access to medicines by committing to establishing bridging funding for medicines; it is wonderful to see an Expert Implementation Group has been established to rapidly co-design a sustainable criteria and model for bridging funding.

Australian patients, their families, and treating clinicians cannot afford the 442 days to make medicines available on the PBS.

The Bridging Funding Coalition now calls on the Government to ensure Australian patients get faster access to medicines by:

  • Committing to establishing bridging funding for medicines, and
  • Establishing an Independent Expert Implementation Group to rapidly co-design a sustainable criteria and model for bridging funding.

Go to www.bridgingfundingaustralia.com.au for more information.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

CAN Forum 2026 – An Opinion Piece

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.